You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-Lymphocytes, Regulatory

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

Recruiting
  • Chronic Graft vs Host Disease
  • Regulatory T-cell enriched infusion
  • Sevilla, Spain
    José Antonio Pérez Simón
May 20, 2022

Deficient T Regulatory Cell Function in Relapsing Remitting

Recruiting
  • Relapse Remitting Multiple Sclerosis
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Jun 13, 2022

    Aplastic Anemia Trial in London (Expanded autologous T regulatory cells)

    Recruiting
    • Aplastic Anemia
    • Expanded autologous T regulatory cells
    • London, United Kingdom
      King's College Hospital
    Aug 16, 2022

    Prostate Cancer Trial in Charleston (Simvastatin 40mg)

    Recruiting
    • Prostate Cancer
    • Simvastatin 40mg
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Nov 30, 2022

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Amyotrophic Lateral Sclerosis Trial in New York (CK0803, Excipient)

    Not yet recruiting
    • Amyotrophic Lateral Sclerosis
    • CK0803
    • Excipient
    • New York, New York
      Columbia University Irving Medical Center
    Jan 26, 2023

    Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

    Active, not recruiting
    • Acute Lymphocytic Leukemia
    • Lymphoma
    • Biological/Genetically Modified T cells
    • Cyclophosphamide-based chemotherapy
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2023

    Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)

    Recruiting
    • Multiple Myeloma
    • TAA-specific CTLs
    • TAA-specific CTLs- fixed dose
    • Houston, Texas
      Houston Methodist Hospital
    Nov 11, 2022

    Mechanistic Studies of Teriflunomide in RRMS

    Active, not recruiting
    • Relapsing Remitting Multiple Sclerosis
    • Ann Arbor, Michigan
      University of Michigan
    Jul 27, 2022

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +2 more
    • SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 13, 2022

    Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

    Recruiting
    • Hodgkins Lymphoma
    • Non Hodgkins Lymphoma
    • TAA-specific CTLs
    • Houston, Texas
      Texas Children's Hospital
    Jul 14, 2022

    Alzheimer Trial in Houston (Aldesleukin)

    Completed
    • Alzheimer Disease
    • Houston, Texas
      Alireza Faridar
    Apr 19, 2023

    Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

    Recruiting
    • Hodgkin's Disease
    • +3 more
    • EBV-specific T cells: A
    • EBV-specific T cells: B
    • Houston, Texas
    • +1 more
    Jun 28, 2022

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

    Recruiting
    • Epstein-Barr Virus Infections
    • Primary Immune Deficiency Disorder
    • cytotoxic t-lymphocytes
    • Los Angeles, California
    • +7 more
    Sep 27, 2022

    Liver Transplant Rejection Trial in Chicago (Erythropoietin)

    Recruiting
    • Liver Transplant Rejection
    • Chicago, Illinois
      Northwestern University
    Apr 5, 2022

    Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

    Recruiting
    • Adenovirus
    • Primary Immune Deficiency Disorder
    • cytotoxic t-lymphocytes
    • Los Angeles, California
    • +8 more
    Sep 27, 2022

    Severe COVID-19 Trial in Thessaloniki (Coronavirus-2-specific T cells, standard of care (SOC))

    Recruiting
    • Severe COVID-19
    • Coronavirus-2-specific T cells
    • standard of care (SOC)
    • Thessaloniki, Greece
    • +1 more
    Nov 22, 2022

    Abdominal Aortic Aneurysm Trial in Indianapolis (MSCs, Placebo)

    Terminated
    • Abdominal Aortic Aneurysm
    • MSCs
    • Placebo
    • Indianapolis, Indiana
      Richard L. Roudebush VA Medical Center, Indianapolis, IN
    Aug 4, 2022

    Horton's Disease Trial in Dijon (Blood samples)

    Completed
    • Horton's Disease
    • Blood samples
    • Dijon, France
      Centre Hospitalier Universitaire
    Mar 4, 2020

    End Stage Renal Disease Trial in Lexington (High Intensity Interval Training)

    Not yet recruiting
    • End Stage Renal Disease
    • High Intensity Interval Training
    • Lexington, Kentucky
      University of Kentucky Transplant Center
    Feb 14, 2022

    Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute

    Recruiting
    • Acute Rejection of Renal Transplant
    • Graft Failure
    • Donor-derived cell-free DNA
    • Loma Linda, California
      Loma Linda University Health
    Jul 19, 2022

    SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

    Recruiting
    • SLE (Systemic Lupus)
    • +4 more
    • CD19 targeted CAR-T cells
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Sep 25, 2023

    The Significance of Release of T-follicular Helper and

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
    • flowcytometry
    • (no location specified)
    Oct 22, 2021

    Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
    • +3 more
    • Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
    • Columbus, Ohio
    • +1 more
    Apr 20, 2022